Collegium Pharmaceutical Inc
COLL
Market Cap$1.1B
Close$
$50.14
54.4% upside
Current Fair Value
54.4% upsideUndervalued by 54.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.10 Billion |
|---|---|
| Enterprise Value | $1.41 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $2.14 |
| Beta | 0.54 |
| Outstanding Shares | 32,715,322 |
| Avg 30 Day Volume | 506,311 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 11.81 |
|---|---|
| PEG | -4.56 |
| Price to Sales | 1.91 |
| Price to Book Ratio | 5.41 |
| Enterprise Value to Revenue | 2.48 |
| Enterprise Value to EBIT | 7.33 |
| Enterprise Value to Net Income | 15 |
| Total Debt to Enterprise | 0.44 |
| Debt to Equity | 2.8 |
Revenue Sources
No data
ESG Score
No data
About Collegium Pharmaceutical Inc
CEO: Joseph Ciaffoni